While classical virology techniques such as virus culture, electron microscopy, or classical PCR had been unsuccessful in identifying the causative agent responsible for the fulminating disease of guinea fowl, we identifi ed a novel avian gammacoronavirus associated with the disease using metagenomics. Nextgeneration sequencing is an unbiased approach that allows the sequencing of virtually all the genetic material present in a given sample.
Introduction
The fi eld of pathogen discovery gained a completely new dimension when new genomics tools, next-generation sequencing (NGS), became available. Isolation and identifi cation by electronic microscopy used to be the gold standard techniques to identify a new pathogen. However, some pathogens are diffi cult to culture, and/ or to separate from co-infecting agents. PCR has improved pathogen discovery, but even when pan-species/Genus/family PCRs may be developed (which is not always possible, especially for highly variable RNA viruses), the primers chosen do condition the nucleic acids that will be amplifi ed: it is still a "biased" technique with which only known (or closely related to known) pathogens whose presence was suspected may be detected [ 1 , 2 ] . NGS allows for (1) massive sequencing of genetic material and (2) unbiased sequencing, to a much lower cost per sequenced base than Sanger sequencing technology. Here we describe an NGS technique that can be used to identify novel pathogens, which we recently used to identify the pathogen responsible for the guinea fowl fulminating disease [ 3 ] . Figure 1 summarizes the methodology used for the identifi cation of a novel guinea fowl gammacoronavirus.
Methods

Materials for Preparation of Specimens and Concentrating Viral Particles
Materials for RNA Extraction and Amplifi cation 2.3 Next-Generation Sequencing
1. Pool intestinal contents of experimentally infected guinea fowl poults and resuspend in 500 μl PBS with penicillin and streptomycin. Vortex.
2. Filter (0.45 μm fi lter) the solution to eliminate eukaryoticand bacterial-cell-sized particles.
3. Centrifuge the digestive content at 10,000 × g for 30 min twice to clarify the solution and collect the supernatant in a new tube.
1. Pellet the concentrated material by ultracentrifugation at 100,000 × g for 2 h.
2. Treat with RNAse and DNAse to remove non-particleprotected nucleic acids: make a mix of 500 μl of sample, 10 μl DNAse (100 U), 12 μl RNAse (20 μg/μl), 60 μl 10× DNAse buffer, 16 μl PBS. Incubate the mix for 20 min at 37 °C and then 10 min at 75 °C to stop the reaction.
1. Add 750 μl TRIzol to 250 μl sample from Subheading 3.2 , step 2 and incubate 5 min at room temperature.
2. Add 200 μl chloroform, vortex vigorously, and incubate 10 min at room temperature.
3. Centrifuge for 15 min at 11,000 × g at 4 °C. 2. ddNTPs are added one by one (one cycle = one ddNTP added, a picture taken and defl uoration of the ddNTP to be able to add a new ddNTP the next cycle) by a DNA polymerase. The addition of ddNTP is digitally recorded as sequence data cycle after cycle.
Sample Preparation
Concentration of Viral Particles
RNA Extraction and Amplifi cation ( See Note 2 )
1. Preprocess the data to remove adapter sequences and demultiplexing using splitbc (several samples can be multiplexed and run together on the MiSeq Illumina sequencer to reduce cost).
Cluster Generation Using the Miseq Reagent Kit (Illumina)
Sequencing on the Miseq (Illumina)
Data Analysis
